Affirm Posts Q1 FY2027 Results as Investors Weigh Growth Against Valuation and Credit Risks

What happened

Affirm Holdings, Inc. announced its fiscal 2027 first quarter results for the period ended September 30, 2026, with a press release that directs stakeholders to its investor relations website and a scheduled conference call. The release provides no financial figures, leaving the market to await the shareholder letter and management commentary for actual performance metrics. The prior DeepValue master report (based on data through late 2025) characterized Affirm as a high-quality BNPL operator with strong GMV and revenue growth, achieving GAAP profitability and positive free cash flow. However, that report also highlighted a 'POTENTIAL SELL' stance due to the stock's extreme valuation (over 200% premium to a conservative DCF) and a leveraged, funding-dependent balance sheet with net debt to EBITDA around 9x and interest coverage near 0.3x. This earnings report serves as a critical checkpoint for whether the company's growth, credit performance, funding access, and regulatory environment have improved enough to justify the rich multiple.

Implication

The Q1 FY2027 earnings release is a key test for Affirm's ability to sustain its high-30% GMV growth and positive free cash flow while managing an increasingly competitive BNPL landscape. Investors should focus on delinquencies and charge-offs, as sector-wide BNPL past-due rates were near 30% in prior data, and any deterioration would undermine the underwriting advantage that underpins the premium multiple. Funding health is equally critical: the company's reliance on securitizations and warehouse lines means that any widening of spreads or reduction in capacity could force slower originations or higher costs, directly hitting profitability. Regulatory developments, particularly any move to treat BNPL like credit cards with respect to disclosure, fees, or capital requirements, could structurally compress unit economics and warrant a lower valuation. Until these risks are resolved favorably, the stock's ~104x trailing earnings and >200% premium to a simple DCF leave little margin of safety, suggesting that investors should remain cautious and await tangible evidence of sustainable value creation before buying.

Thesis delta

The earnings release itself does not alter the prior thesis: the company remains an attractive growth story but the equity is priced for perfection with high leverage and regulatory/credit risk. Consequently, the POTENTIAL SELL stance from the master report is maintained pending detailed financial disclosures from the filing and call.